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EVIDENCE FOR A REGULATORY ID IOTYP IC  NETWORK IN 
THE IN V IVO RESPONSE TO H°2 ANT IGENS 
BY RUTH RABINOWITZ, JEFFREY A. BLUESTONE, AND DAVID H. SACHS 
From the Transplantation Biology Section, Immunology Branch, National Cancer Institute, 
National Institutes of Health, Bethesda, Maryland 20205 
One of the central questions in immunology concerns pecific regulation of 
antibody responses. Jerne (1) proposed that interactions between idiotype (Id) 1 
and antiidiotype (anti-Id) constitute a key element in such regulation, leading to 
the concept of immunoregulatory networks. Subsequently, numerous examples 
of idiotypic regulation have been described. The production of anti-Id antibody 
has been demonstrated during normal immune responses (2-4). In addition, 
exogenously administered anti-Id antibody has been found to regulate relevant 
Id-specific antibody responses (5-9) and to induce suppressor T lymphocytes 
(10-13). In classical systems (15), treatment of animals with anti-Id leads to the 
induction of antigen-nonbinding Id-positive molecules. 
In our laboratory extensive studies of anti-major histocompatibility complex 
(MHC) Id have been performed in recent years (16-19). Among the xenogeneic 
anti-Id reagents that have been raised are several against anti-H-2K kmonoclonal 
antibodies (8, 20). Treatment of mice in vivo with those xenogeneic anti-Id has 
been found to induce the production of serum antibodies (Id') that bear some 
of the idiotopes of the original monoclonal anti-MHC antibody, but which have 
unknown binding specificity. In addition, some mice treated with anti-Id devel- 
oped antigen-binding activity for the original MHC antigen, even though they 
had never been exposed to that antigen (20). 
In the present report we examine the Id network involved in immune responses 
to MHC antigens. The effect of subsequent immunization of anti-Id-primed 
mice with the original MHC antigen was examined. The experiments described 
here demonstrate hat boosting with skin grafts bearing the original H-2 antigens 
leads to increased levels of Id'-positive, antigen-nonbinding molecules, as well as 
antigen-binding molecules, in the serum of the immunized mice. In contrast, 
boosting with other irrelevant antigens had no effect on either Id-positive 
population. These findings support strongly the existence of network interactions 
invoked after anti-Id treatment that may be involved in the control of subsequent 
responses to H-2 antigens. 
Address correspondence to D. Sachs. Current address of R. Rabinowitz is The Hubert H. Humphrey 
Center for Experimental Medicine and Cancer Research, The Hebrew University-Hadassah Medical 
School, Jerusalem, Israel. 
l Abbreviations used in this paper: BSA, bovine serum albumin; ELISA, enzyme-linked immuno- 
sorbent assay; FACS, fluorescence-activated c ll sorter; FCS, fetal calf serum; FMF, flow microfluo- 
rometry; Id, idiotype; Id', idiotype-bearing molecules; MHC, major histocompatibility complex; 
NMS, normal mouse serum; NPIg, normal pig lg; PBS, phosphate-buffered saline. 
Journal of Experimental Medicine • Volume 162, August 1985 745-755 745 
746 REGULATORY IDIOTYPIC NETWORK TO H-2 ANTIGENS 
Mater ia l s  and  Methods  
Animals. BALB/cAnN mice were obtained from Charles River Breeding Laboratories, 
Inc. (Wilmington, MA). BALB.K mice were bred in our animal colonies. B10.A and 
B 10.D2 mice were obtained from The Jackson Laboratory (Bar Harbor, ME). F-344 rats 
were purchased from the NCI-Frederick Cancer Research Facility (Frederick, MD). 
Monoclonal Antibodies. Clone 11-4.1 (IgG2a,K) was raised in a BALB/c mouse immu- 
nized with CKB spleen cells by Oi et al. (21) and obtained through The Salk Institute 
(San Diego, CA). The antibodies of this clone are specific for the H-2K k antigen with 
crossreactivities against antigens of the K q and the H-2 p'r haplotypes. The myeloma LPC- 
1 (IgG2a,x) was obtained from Dr. M. Potter. 
Preparation ofXenogeneic Anti4d. Miniature swine and rabbits were immunized with 
protein A-purified 11-4.1 antibodies in complete Freund's adjuvant by several intraperi- 
toneal injections. Details of the immunization scheme and preparation of anti-ld have 
been described previously (20). Briefly, immune sera were fractionated on Sepharose 4B 
coupled with LPC-1 to remove antibodies to normal mouse Ig. This procedure has been 
shown previously to remove all anti-constant region antibodies (20). This procedure was 
repeated several times to ensure the removal of anti-constant region antibodies. Specific 
anti-Id antibodies were then obtained by affinity chromatography on Sepharose 4B 
coupled with 11-4.1 monoclonal antibody. 
In Vivo Treatment of Mice. BALB/c mice were injected intraperitoneally with 20 tag of 
pig anti-ld in phosphate-buffered saline (PBS) on day 0 and 3. Control mice were 
immunized with 20 tag purified normal pig Ig (NPIg) on day 0 and 3. Id'  levels, assessed 
by enzyme-linked inmmnosorbent assay (ELISA), were detectable within 7 d after immu- 
nization. Skin grafting of mice was performed using tail skin from either BALB.K or 
B10.D2 mice or Fisher rats. Sera of skin grafted mice were usually tested 21 d after skin 
grafting. In some experiments skin-grafted mice were boosted by interperitoneal injection 
of 1 x 10 v spleen cells. Sera were collected 1 wk after each immunization. 
ELISA Inhibition Assay for Detection of ld. ELISA assays were performed as described 
in detail previously (9). Briefly, microELISA plates (Nunc, Roskilde, Denmark) were 
coated with 200 tal of protein A-purified 11-4.1 antibodies at 1 tag/ml in PBS overnight 
at 4°C. The ELISA assay was performed in 0.05% PBS-Tween 20 (Sigma Chemical Co., 
St. Louis, MO) to reduce nonspecific binding. 
Test sera from either pig anti-Id' or NPIg-immunized mice were serially diluted in 25- 
50 ul volumes and incubated with 25 tal of NPIg (2 tag/ml) to inhibit potential anti- 
constant region antibodies. Simultaneously, anti-Id preparation was diluted to the appro- 
priate concentration and swamped with 10% normal mouse serum (NMS). Rabbit anti-Id 
preparation was used to avoid inhibition by anti(anti-Id) antibodies. 
After these preincubations, rabbit anti-Id was added to the test sera, and the mixtures 
were incubated for 60 min and transferred to the 11-4.1-coated ELISA plates. Binding 
of rabbit anti-Id to the 11-4.1-coated plate was detected 60 rain later wtih horseradish 
peroxidase-coupled goat anti-rabbit IgG (Cappel Laboratories, Cocbranville, PA). En- 
zyme bound to plates was then exposed to an excess of substrate, o-phenylenediamine 
(Aldrich Chemical Co., Milwaukee, WI). The reaction was stopped by adding 8 N H2S04. 
Absorbance at 492 nm was measured by a TiterTek Multiskan spectrophotometer (Flow 
Laboratories, McLean, VA). Standard errors were always <10%. Percent inhibition was 
calculated according to the formula: percent inhibition = [0D492 (uninhibited) - 00492 
(test sample)/OD4.~2 (uninhibited)] x 100. 
Complement-mediated Cytotoxicity. Two stage microcytotoxicity assays were performed 
as described previously (22) using media 199 (Gibco Laboratories, Grand Island, NY) 
containing 10% fetal calf serum (FCS). 5 x 104 5~Cr-labeled target cells in 25 tal were 
mixed with 25 tal of various antiserum dilutions in microtiter wells, incubated 15 min at 
37°C, washed, and then treated for 30 min at 37°C with appropriately diluted rabbit 
complement (C'). Lysis was determined by counting 5~Cr eleased from the labeled target 
cells. Percent lysis was calculated by the formula: specific 5~Cr release = [experimental 
(cpm) - complement alone (cpm)/maximum (cpm) - complement alone (cpm)] x 100. 
Fluorescence Measurement by Flow Microfluorometry (FMF). FMF was performed using a 
RABINOWITZ, BLUESTONE, AND SACHS 747 
fluorescence-activated cell sorter (FACS II; Becton Dickinson Immunocytometry Systems, 
Mountain View, CA). Detailed procedures for the operation of the sorter and data 
collected have been reported previously (23). 1 x 106 B10.A lymph node cells were 
incubated for 45 rain at 4 °C with 25 #1 of a mixture of fluoresceinated goat F(ab')z anti -  
mouse lgG2 and F(ab').~ anti-mouse IgG1 at a final dilution of 1:64 of each antibody. 
The suspension was incubated for 30 min at 4°C, washed, and resuspended in 0.4 ml for 
analysis by FMF. All staining procedures were carried out in Hanks' balanced salt solution 
containing 0.1% bovine serum albumin (BSA) and 0.1% sodium azide. Fluorescence data 
were collected using 5 x 104 viable cells as determined by forward light scatter intensity 
and the results were displayed as a curve with cell number plotted on the ordinate and 
fluorescence intensity on the abscissa. Fluorescence units were arbitrary values selected 
on the basis of the fluorescence intensity of positively stained cells. 
Absorption Procedure. Sera from anti-Id-treated mice were absorbed with either 
BALB.K spleen cells or BALB/c spleen cells at 100 #1 of serum per 1-3 X l0 s washed, 
packed spleen cells. The absorption mixtures were kept 1 h at 4°C, mixed occasionally, 
centrifuged, and the supernates were collected. 
Results 
In Vivo Treatment of Mice with Anti-ld. We have previously reported (8, 20) 
that BALB/c mice treated with pig anti-11.4.1 anti-ld produced Id'-bearing 
molecules capable of inhibiting the binding of anti-11-4.1 anti-Id to 11-4.1- 
coated ELISA plates. A time course study (Fig. 1) demonstrated that, after 
injection of 20 #g of pig anti-11-4.1 on days 0 and 3, significant serum levels of 
Id'-bearing molecules, which inhibited the binding of anti-Id to 11-4.1-coated 
plates, were detected as early as day 7 and were present at the same high level 
at least 3 wk after treatment. At week 5, in a high proportion of the in vivo 
immunized mice, the level of Id' serum reactivity began to decrease. At week 
10, only a low level of Id' molecules could still be detected in the immune sera 
(Fig. 1). As has been previously reported (25) only 20% of such anti-Id- 
immunized mice developed etectable anti-H-2K k activity, as assessed by cell- 
bound fluorescence quantified by FMF on the FACS (not shown). 
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F~C, URE 1. Induction of Id-positive molecules by in vivo treatment. Individual BALB/c mice 
were treated with either 20 #g of pig anti-ld (0) or 20 ug of NPIg (O) on day 0 and 3 and 
their sera subsequently assayed for their ability to inhibit he binding of rabbit anti-ld to Id- 
coated ELISA plates, as described in Materials and Methods. 
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FIGURE 2. The effect of alloimmunization the induction of Id-positive molecules and 
cytotoxic antibodies. BALB/c mice were skin grafted with BALB.K tail skin. 3 wk later sera 
from individual mice were tested for their ability to either inhibit the binding of rabbit anti- 
Id to Id-coated ELISA plates (O) or to lyse B10.A spleen cells (O) in the presence of 
complement. 
In contrast o anti-Id immunization, treatment of BALB/c mice with 20 ug 
NPIg did not induce any significant level of Id' molecules (Fig. 1) above the 
inhibition seen by NMS. None of the mice so treated developed etectable anti- 
H-2K k activity. 
Treatment of Naive BALB/c Mice with H-2K k. It was of  interest to examine 
whether alloimmunization with H-2K k antigen would have any effect on the 
induction of Id'-bearing molecules. Alloantisera to H-2K k antigen, obtained 
from BALB/c mice that were skin grafted with BALB.K tail skin, were tested 
for their ability to inhibit the binding of  xenogeneic anti-11-4.1 anti-Id to 11- 
4.1-coated ELISA plates. Inhibition of Id-anti- Id interaction in ELISA was not 
detectable with any of the alloantisera tested (Fig. 2). In contrast, all of the sera 
tested showed a significant anti-H-2K k reactivity when assayed by microcytotox- 
icity analysis (Fig. 2) or by direct cell-bound fluorescence quantified by FMF (not 
shown). These results suggested that the majority of anti-H-2K k antibodies 
induced in BALB/c mice by BALB.K skin grafts do not express the 11-4.1 
idiotype. 
Treatment of Anti-11-4. I Anti-Id-treated BALB/c Mice with H-2K k Antigen. The 
effect of alloimmunization on the expression of Id-bearing molecules in anti- Id- 
treated mice was next examined. Both anti - Id-primed mice and NPIg-treated 
mice were grafted with BALB.K skin. Skin grafting was performed 7 wk or more 
after Id'  molecules decreased. Sera from anti- Id-primed BALB/c mice contained 
levels of  Id'  serum reactivity after skin grafting with BALB.K skin, which were 
as high as the level of Id'  detected immediately after immunization with anti-Id 
(Figs. 3A and 5). In contrast, NPIg-primed mice that were skin grafted with 
BALB.K skin did not show any significant amount of Id' serum reactivity when 
tested by ELISA inhibition assay (Fig. 3B). 
The  increased serum levels of  Id' molecules in sera of anti - Id-primed mice 
was first evident after skin grafts were fully rejected, and remained at the same 
high level for at least 3 wk. The  amount of Id'  molecules continued to decrease 
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FIGURE 3. The  effect of  subsequent anti-H-2K k immunizat ion on Id-bearing molecules. 
BALB/c mice were first treated with either 20 ug of  pig anti- ld (A) or 20 ug NPIg (B) on day 
0 and 3. Skin graft ing of  the mice was per formed 7 wk later using tail skin of  BALB.K. The  
ability of  sera from individual mice to inhibit the binding of  rabbit anti-Id to Id-coated ELISA 
plates was tested at different ime intervals before and after skin grafting. 
until skin grafts were fully rejected, but increased thereafter. These findings 
suggested that the increased level in Id' molecules after skin grafting was the 
result of an antigenic stimulation. Absorption studies were performed to deter- 
mine whether the increased level of Id'-binding molecules that could now be 
detected in the sera of anti-Id-primed mice by ELISA represented an increase 
in the amount of anti-H-2K kId-positive antibodies or antigen-nonbinding mole- 
cules. In all sera tested, anti-H-2K kreactivity, as detected by a microcytotoxicity 
assay, was fully removed by absorption with BALB.K spleen cells (Fig. 4, Table 
I). In two of four individual sera, such absorption (which removes all anti-H-2 k
activity, data not shown) did not have any effect on the capacity of the sera to 
inhibit the Id-anti-Id interaction in the ELISA (Fig. 4, Table I). In sera from 
mice 1279 and 1284, absorption with BALB.K spleen cells partially removed the 
inhibitory capacity of the sera. However, the level of Id' was still greater than 
that observed before skin grafting. These findings suggest hat the level of 
antigen-nonbinding Id' increased after exposure to the H-2K k antigen. 
Effect of Irrelevant Antigen Immunization on ld'-bearing Molecules. The above 
described experiments could be the result of either specific Id-anti-Id interac- 
tions or of a nonspecific effect of antigen immunization. To distinguish among 
these possibilities, anti-Id-primed mice were skin grafted with either B10.D2 
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FIGURE 4. The effect of absorption of  anti-H-2K kactivity on the level of  Id + molecules and 
cytotoxic antibodies. Mouse 1276 was first immunized with pig anti-Id and then skin grafted 
with BALB.K tail skin as described in Fig. 3. Three weeks after skin grafting, serum from 
mouse 1276 was absorbed with either BALB/c spleen cells or BALB.K spleen cells, and 
thereafter the absorbed sera were tested for their ability to either inhibit the Id-anti- ld 
interaction in ELISA (right) or to lyse in the presence of complement and B10.A target cells 
(/eJ2); unabsorbed serum (@), serum ~t~osorbed with BALB/c spleen cells (I), sermn absorbed 
with BALB.K spleen cells (A). 
TABLE I 
Effect of Absorption of Anti-H-2K k Activity on the Level of ld'  
Molecules 
Mouse 
No. 
Percent inhibition of anti-ld binding 
Before After skin graft skin graft 
Unab- Absorbed Absorbed Unabsorbed sorbed with with serum serum BALB/c BALB.K 
1284 43 65 58 50 
1276 NT 72 68 66 
1985 27 46 43 40 
1979 23 58 60 41 
BALB/c mice were first immunized on day 0 and 3 with pig anti-Id and 
then skin grafted on week 7 with BALB.K tail skin. Sera from individual 
mice were collected before and after skin grafting, absorbed with either 
BALB/c spleen cells or BALB.K spleen cells, and tested for their ability 
to inhibit the binding of  rabbit anti-ld to Id-coated ELISA plates. 
(i.e., a source for a non-H-2 antigen) or rat skin (a source for a xenogeneic 
antigen), and the sera of the skin-grafted mice were tested for their capacity to 
inhibit Id-anti- Id binding in EL1SA. Figs. 5-7 describe the results of such 
experiments. In contrast o BALB.K skin, which induced a high serum level of 
Id'  molecules (Fig. 5), neither B10.D2 skin (Fig. 6) nor rat skin (Fig. 7) had any 
effect on the level of Id' reactivity. When the various sera were tested in a 
microcytotoxicity assay for the presence of antibody activity against he appro- 
priate spleen cells, although both BALB.K and rat skin induced a significant 
level of cytotoxic antibodies (100% killing of the appropriate spleen cells with 
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FIGURE 5. The  effect of  subsequent immunizat ion with BALB.K tissues on Id' -bearing 
molecules. BALB/c mice first immunized with pig anti-Id were skin grafted 17 wk after anti- 
Id injection with BALB.K tail skin. Boosting with BALB.K spleen cells were per formed at 
weeks 23 and 25. Sera from individual mice were assayed for their ability to inhibit ]d-anti-  
Id interaction in ELISA at different ime intervals dur ing the immunizat ion schedule. 
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FIGURE 6. The  effect of  subsequent immunizat ion with B10.D2 tissues on Id' -bearing 
molecules. BALB/c mice first immunized with pig anti-Id were skin grafted 17 wk after anti- 
Id injection with B10.D2 tail skin. Boosting with B10.D2 spleen cells were performed at weeks 
23 and 25. Sera from individual mice were assayed for their ability to inhibit Id-anti - Id 
interaction in ELISA at different time intervals dur ing the immunizat ion schedule. 
titers of 1:27 to 1:81), B10.D2 skin did not induce detectable antibody activity 
(cytotoxic titers, <2). Additional boosting of the mice with B10.D2 spleen cells 
led to increased levels of cytotoxic antibodies (titers 1:16 to 1:32 after the second 
injection), but did not have any significant effect on the level of Id' reactivity in 
the immune sera (Fig. 6). Boosting of the mice with BALB.K spleen cells led to 
increased cytotoxic titers (titers 1:81 to 1:243 after the second injection) and 
persistent high levels of Id' reactivity in the immune sera tested (Fig. 5). These 
results indicated that only the original H-2K k antigen affected the production of 
Id + antigen-nonbinding molecules. 
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FIGURE 7. The  effect of  subsequent immunizat ion with rat skin on ld-bearing molecules. 
BALB/c mice first immunized with pig anti- ld were skin grafted 14 wk after anti-Id injection 
with rat tail skin. The  ability of  sera from individual mice to inhibit the binding of  rabbit anti- 
Id to Id-coated ELISA plates was tested at different time intervals before and after skin 
grafting, 
Discussion 
The experiments described in the present study demonstrate he ability of H- 
2K k antigen to affect specifically the product of Ig molecules bearing the same 
idiotypic determinants as 11-4.1, but without detectable reactivity with the 
immunizing H-2K k antigen. 
The generation of antigen-nonbinding Id'-positive molecules after anti-Id 
immunization has previously been reported in several experimental systems (14, 
15, 26, 19) including the anti-H-2K k system studied here (8, 20, 24, 25, 30). 
This phenomenon suggests that anti-ld in some way triggers the expansion of B 
cell clones bearing similar idiotypic determinants o those toward which the anti- 
Id is directed. The actual mechanism involved in the regulation of such idiotype- 
positive B cell clones is still unknown. Bluestone t al. (16) found that F(ab')2 
fragments of rabbit anti-11-4.1 did not lead to the production of Id'-positive 
molecules. On the basis of this finding, it was suggested that the expansion of 
those B cell clones is, in part, dependent on T cell helper factors probably 
generated by recognition of Fc molecules as carrier determinants (14). Our 
present findings, that only BALB.K skin bearing the H-2K k antigen but not 
B 10.D2 or rat skin boosted the serum level of antigen-nonbinding Id' molecules, 
could be interpreted as indicating that H-2K k antigen triggered in a specific way 
B cell clones secreting low affinity antigen-binding antibodies that could not be 
detected by binding to test cells. Alternatively, H-2K k antigen, like anti-Id, could 
trigger antigen-nonbinding idiotype-positive B cell clones. If the latter explana- 
tion is correct, our findings suggest strongly the existence of Id-anti-Id regula- 
tory networks in the response to H-2K k antigen. Thus, the administration of H- 
2K k antigen may induce in mice a syngeneic anti-Id antibody or T cell response 
which, like xenogeneic anti-Id, restimulates those B cell clones bearing the same 
idiotypic determinants. Indeed, it has previously been reported (24) that synge- 
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neic anti-ld antibodies against monoclonal anti-H-2 antibodies recognize idi- 
otypes on antibodies induced by xenogeneic antMd reagents. 
To demonstrate the existence of such an Id-anti-Id regulatory mechanism in 
the response to H-2K k antigen, it was necessary to use anti-Id-primed mice. Skin 
grafting of normal BALB/c mice with BALB.K skin did not generate any 
detectable idiotypic activity when tested in ELISA, probably because the 11-4.1 
idiotype, used to generate the anti-Id reagent, constitutes a very minor propor- 
tion of the humoral response to H-2K k antigen, and therefore could not be 
detected in ELISA due to the sensitivity of the assay. In manipulated mice, 
however, Id that ordinarily constitute only a minor proportion had been induced 
by antMdiotype to represent a very large proportion of that same response. This 
provides an experimental model for studying the concept of immunoregulatory 
network. 
Using another experimental system and the cell-bound fluorescence inhibition 
assay (20), in some conventional anti-H-2K k alloantisera that did not show any 
idiotypic activity in ELISA, a fraction of the antigen-binding molecules were 
found to possess the 11-4.1 Id (unpublished ata). This finding is different from 
one previously reported (25) and may suggest hat the 11-4.1 Id is more public 
than previously thought. 
The actual cellular pathway involved in B cell stimulation by anti-Id is still 
unknown. Experiments done in nu/nu mice both in the antinuclease system (29) 
and anti-H-2K k system (25) indicate that B cell stimulation by anti-Id requires 
functional T cells. The experiments reported here do not directly address the 
issue of T cell involvement in the expression of anti-H-2 B cell Id. However, 
taking into consideration the fact that B cell surface receptors are identical to 
their secreted antibodies, it is unlikely that H-2K k antigen which restimulated 
the secretion of antigen-nonbinding Id' molecules had bound directly to those 
B cells that secreted non-H-2Kk-binding antibodies. Thus, intermediate path- 
ways, possibly involving T cells, may operate to produce this effect. The exact 
nature of such pathways remains uncertain. The simplest explanation may be 
that H-2K k antigen acts directly on Id-bearing, antigen-specific B cells. Subse- 
quently, such B cells or their product might induce anti-Id helper T cells (or 
antibodies) which, in turn, activate Id'-binding and -nonbinding B cell clones. 
Summary 
Treatment of BALB/c mice with purified pig antiidiotype to 11-4. I (anti-H- 
2K k) monoclonal antibody has been found previously to induce the appearance 
of idiotype-bearing molecules (Id') in the serum of these mice, in the absence of 
detectable antigen-binding activity. In the present study we examined the effect 
of subsequent immunization of such antiidiotype-primed mice with the original 
H-2K k antigen. Skin grafting of virgin BALB/c mice with BALB.K skin did not 
generate any detectable Id' antibodies when tested by enzyme-linked immuno- 
sorbent assay (EL1SA). In contrast, grafting of antiidiotype-primed mice with 
BALB.K skin specifically boosted the serum level of Id' molecules. Challenge of 
antiidiotype-primed mice with either B10.D2 or rat skin had no effect on the 
production of such ld' molecules. Absorption studies demonstrated that the 
majority of ld' molecules induced by H-2K k antigenic stimulus and detected in 
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ELISA are antigen-nonbinding molecules, thus indicating specific restimulation 
by the original H-2K k antigen of nonbinding idiotype-positive B cell clones. The  
relevance of these findings to the existence of network interactions in the immune 
response to H-2 antigens is discussed. 
Received for publication 7 March 1985 and in revised form 24 April 1985. 
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